Cryptocarya-derived natural products were reported to have several biological effects such as the antiproliferation of some cancers. The possible antioral cancer effect of Cryptocarya-derived substances was little addressed as yet. In this study, we firstly used the methanolic extracts of C. concinna Hance roots (MECCrt) to evaluate its potential function in antioral cancer bioactivity. We found that MECCrt significantly reduced cell viability of two oral cancer Ca9-22 and CAL 27 cell lines in dose-responsive manners ( < 0.01). The percentages of sub-G1 phase and annexin V-positive of MECCrt-treated Ca9-22 and CAL 27 cell lines significantly accumulated ( < 0.01) in a dose-responsive manner as evidenced by flow cytometry. These apoptotic effects were associated with the findings that intracellular ROS generation was induced in MECCrt-treated Ca9-22 and CAL 27 cell lines in dose-responsive and time-dependent manners ( < 0.01). In a dose-responsive manner, MECCrt also significantly reduced the mitochondrial membrane potential in these two cell lines ( < 0.01-0.05). In conclusion, we demonstrated that MECCrt may have antiproliferative potential against oral cancer cells involving apoptosis, ROS generation, and mitochondria membrane depolarization.
Introduction
Oral squamous cell carcinoma (OSCC) is a type of cancer that frequently occurs in oral cavity. Although it is comparatively easy to clinically inspect by a dentist or to detect by some OSCC tumor markers [1, 2] , this carcinoma is usually ignored by patients especially for the early stage. Subsequently, OSCC is frequently diagnosed at advanced stages which then lead to high mortality [3] . Therefore, the drug development of antioral cancer is still necessary and remains to be a challenge.
Natural products have improved the drug discovery for anticancer therapy [4] . For example, some anticancer
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Cell Cultures and Methanolic Extracts of C. concinna.
Two human OSCC cell lines Ca9-22 and CAL 27, purchased from the Cell Bank, RIKEN BioResource Center (Tsukuba, Japan) and the American Type Culture Collection (ATCC; Virginia, USA), respectively, were incubated in DMEM/F12 (3 : 2) medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin, 100 g/mL streptomycin, and 0.03% glutamine.
These two cell lines were humidly incubated at 37 ∘ C with 5% CO 2 in the humid atmosphere.
C. concinna was identified by one of the authors (IhSheng Chen) and its roots were collected at Mudan, Pingtung County, Taiwan, in May 2004. A voucher specimen (Chen 6153) has been deposited in the Herbarium of the School of Pharmacy, College of Pharmacy, Kaohsiung Medical University. The dried roots of C. concinna were processed by slicing and cold methanol-extraction for three times at room temperature. Finally, the solution was evaporated under reduced pressure to yield the methanolic extract (MECCrt). MECCrt was stored at −20 ∘ C and dissolved in dimethyl sulfoxide (DMSO) before treatment.
Cell Viability.
Cell viability was measured by the CellTiter 96 AQueous one solution cell proliferation assay (MTS) (Promega Corporation, Madison, WI, USA) as previously described [11] . Ca9-22 and CAL 27 cell lines were seeded at a density of 1 × 10 5 and 2 × 10 5 cells per well in a 6-well plate, respectively. After plating for 24 h, these cells were incubated with different concentrations of MECCrt for 24 h and finally subjected to a MTS assay applying an ELISA reader at 490 nm.
Cell Cycle Progression and Sub-G1 Population.
Propidium iodide (PI, Sigma, St. Louis, MO, USA) was added to stain the cellular DNA content [29] . In brief, 3 × 10 5 cells per well in 6 well plates were plated for 24 h and then treated with vehicle (DMSO; 1 L/2 mL culture medium) as a control or 5, 10, 15, 20, and 25 g/mL of MECCrt for 24 h. After exposure termination, cells were centrifuged, washed twice with PBS, fixed overnight with 70% ethanol, and centrifuged. Subsequently, the cell pellets were resuspended in 50 g/mL PI reagent and stand for 30 min at 37 ∘ C in darkness. Cell cycle distribution was evaluated by a flow cytometer (BD Accuri C6; Becton-Dickinson, Mansfield, MA, USA) and a BD Accuri C6 Software (version 1.0.264).
Apoptosis.
To validate apoptosis in MECCrt-treated oral cancer cells, annexin V (Strong Biotect Corporation, Taipei, Taiwan) [30] /PI (Sigma, St Louis, MO, USA) method was used [31] . Briefly, 3 × 10 5 cells per well in 6 well plates were plated for 24 h and then treated with vehicle or indicated concentrations of MECCrt for 24 h. Subsequently, apoptotic cells were stained for 30 min with 100 L binding buffer containing 2 L of annexin-V-fluorescein isothiocyanate (FITC) stock (0.25 g/ L) and 2 L of PI stock (1 mg/mL). Finally, it was suspended with 400 L PBS for analysis of a flow cytometer (BD Accuri C6; Becton-Dickinson) and its software.
Intracellular ROS.
The dye 2 ,7 -dichlorodihydrofluorescein diacetate (DCFH-DA) was used to detect ROS by its fluorescence change [7] . Cells at the density of 3 × 10 5 in 2 mL medium per well in 6 well plates were plated for 24 h. Different concentrations of MECCrt were added to Ca9-22 cells for 6 h and 12 h. After washing with PBS, 100 nM DCFH-DA in PBS was added to cells in 6 well plates at cell culture incubator for 30 min. After trypsinization, PBS washing, and
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Mitochondrial Membrane Potential.
MitoProbe DiOC 2 (3) assay kit (Invitrogen, Eugene, OR, USA) was applied to analyze mitochondrial membrane potential (MMP) as described previously [10] . Briefly, 3 × 10 5 cells in 2 mL medium per well in 6 well plates were plated for 24 h. After MECCrt treatment, 10 L of 10 M DiOC 2 (3) was added per well and incubated in a cell culture incubator for 20 min. After being harvested, cells were washed and resuspended in 1 mL PBS for analysis using a flow cytometer (BD Accuri C6; Becton-Dickinson) and its software.
Statistical Analysis.
The significance of differences was determined by Student's -test compared with the test data with the vehicle controls. Data are expressed as means ± SDs.
Results
Antiproliferation in MECCrt-Treated Two Oral Cancer
Cell Lines. Based on MTS assay (Figure 1 ), the relative cell viability (%) of oral cancer Ca9-22 cells at indicated concentrations of MECCrt (0, 5, 10, 15, and 20 g/mL) was 100.0 ± 0.7, 93.3 ± 2.3, 71.4 ± 3.0, 57.6 ± 1.6, and 48.4 ± 1.2, after 24 h, respectively. The relative cell viability (%) of CAL 27 cells at indicated concentrations of MECCrt (0, 5, 10, 15, and 20 g/mL) was 100.0 ± 0.8,119.3 ± 4.9, 86.9 ± 10.0, 29.8 ± 6.2, and 28.4 ± 5.5, respectively. The MTS-based cell viabilities of MECCrt-treated two oral cancer Ca9-22 and CAL 27 cell lines significantly reduced in a dose-responsive manner ( < 0.01 compared to the vehicle). 
Sub-G1 Population in MECCrt-
Apoptosis of MECCrt-Treated Two Oral Cancer Cell Lines.
To validate the possible outcome of apoptosis in MECCrtinduced sub-G1 accumulation of these two oral cancer cells, annexin V/PI profiles of flow cytometry were generated (Figure 3(a) ). In Figure 3 
ROS Generation in MECCrt-
Discussion
We discovered for the first time that methanolic extracts of the roots of C. concinna Hance have an antiproliferative effect on two oral cancer cell lines. The proliferation inhibiting function of MECCrt against oral cancer Ca9-22 and CAL 27 cell lines was dose-responsive ( Figure 1 ).
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(b) * * * * * * * * * * * * * * * * * * * * The Scientific World Journal [27] . These Cryptocarya-derived compounds from methanolic extracts of nonroot parts showed the IC 50 values ranging from 0.8 to 11 M. This is close to our preliminary result that the IC 50 of the clinical anticancer drug cisplatin at 24 h treatment in oral cancer Ca9-22 cells is 3.06 g/mL (10.2 M) (data not shown). In the present study, the IC 50 values of the MECCrt in oral cancer Ca9-22 and CAL 27 cell lines at 24 h were 18.67 and 13.22 g/mL, respectively. Although the IC 50 values of the MECCrt were about 3-4 folds of cisplatin for oral cancer cells, its crude extract nature has to be concerned. Therefore, it is warranted to further investigate the particular bioactive components that are included in the methanolic extracts of Cryptocarya concinna Hance roots.
Moreover, the anticancer effect for trunk bark of C. infectoria-derived methanol extracts was reported to be cytotoxic to KB cells [24] . KB cells were regarded as oral epidermal carcinoma, however, it was recently validated to have marker chromosomes and DNA finger printings of human cervical cancer HeLa cells (http://www.ncbi.nlm.nih.gov/mesh?Db=mesh&term= KB+Cells) [32] . Accordingly, the anticancer effect of oral cancer by the bioactive compounds from Cryptocarya plant remains unclear. Conversely, we here demonstrate the antioral cancer effect of methanolic extracts of a Cryptocarya species for the first time, using two OSCC cell lines Ca9-22 and CAL 27.
In several anticancer drugs [6, 7, 10, 11, [33] [34] [35] [36] , ROS generation is one of the common strategies to inhibit cancer cell proliferation. ROS plays a vital role in early stages of apoptosis [37] and leads to MMP depolarization [38, 39] . Escaping apoptosis is demonstrated to be involved in the drug resistance of cancer cells [40, 41] . To enhance apoptotic induction of anticancer drugs may interfere the drug resistance if there. In the present study, we observed that apoptosis was inducible by MECCrt in two OSCC cell lines as it was demonstrated by sub-G1 monitoring and annexin V/PI assay. We also found that MECCrt significantly induced the ROS level and reduced the MMP level in two oral cancer cell lines in dose-responsive ways. These findings suggest that oxidative stress may be involved in the MECCrt-induced antiproliferative effect in two oral cancer Ca9-22 and CAL 27 cell lines. However, the role of oxidative stress in MECCrt need to be further examined by the ROS scavenger such as N-acetylcysteine [42] to confirm if raised ROS has played a critical role in the process of apoptosis. Furthermore, the ROS may generate nonapoptotic effect like autophagy described in literature [43, 44] . Therefore, it was warranted to further investigate the role of autophagy in MECCrt-treated oral cancer cell lines in future.
Conclusions
We demonstrated the antiproliferative and apoptotic effects of MECCrt through ROS generation and mitochondrial depolarization in two OSCC cell lines. Therefore, these results suggest that MECCrt has anticancer potential for oral cancer therapy.
